SKK
ARGS

Shepherd Kaplan Krochuk’s Argos Therapeutics, Inc. ARGS Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,135
Closed -$228K – 629
2014
Q3 		$228K Sell
1,135
-529
-32% -$82.7K 0.03% 414
2014
Q2 		$267K Sell
1,664
-1,178
-41% -$195K 0.03% 393
2014
Q1 		$568K Buy
+2,842
New +$568K 0.07% 200

Other funds holding ARGS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.54% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Shepherd Kaplan Krochuk's ARGS Position: Q4 2014 in Review

Shepherd Kaplan Krochuk sold out of Argos Therapeutics, Inc. (ARGS) in Q4 2014, closing a stake of 1,135 shares — an estimated $228K sold.

Shepherd Kaplan Krochuk first reported a position in ARGS in Q1 2014 and held it in 3 quarters. The position peaked at $568K in Q1 2014. 26 funds tracked by Wall St. Rank hold ARGS as of Q4 2014.

  • Shepherd Kaplan Krochuk reported no remaining Argos Therapeutics, Inc. position as of Q4 2014 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 1,135 Argos Therapeutics, Inc. shares in Q4 2014, an estimated $228K.
  • Shepherd Kaplan Krochuk first reported a position in Argos Therapeutics, Inc. in Q1 2014 and held it in 3 quarters.
  • Shepherd Kaplan Krochuk's Argos Therapeutics, Inc. position peaked at $568K in Q1 2014.
  • 26 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2014, filed 17 Feb 2015.